USE OF CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN COVID-ASSOCIATED DIABETIC DEBUT

Authors

DOI:

https://doi.org/10.61651/rped.2026v78n2p32-36

Keywords:

SARS-CoV-2, continuous renal replacement therapy, diabetes mellitus , pediatrics, acute kidney injury

Abstract

Type 1 diabetes mellitus is an autoimmune-mediated and environmentally triggered disease that leads to insulinopenia and hyperglycemia. Its fatal complications include diabetic ketoacidosis (DKA) and rhabdomyolysis. During the 2019 pandemic, SARS- CoV-2 infection presented severe forms associated with systemic hyperinflammatory states and may be linked to acute kidney injury (AKI). While continuous renal replacement therapy (CRRT) is utilized in critically ill patients with AKI, its use in children with DKA remains rare. We present the case of a patient diagnosed with type 1 diabetes mellitus and severe ketoacidosis associated with acute SARS-CoV-2 infection who required CRRT. The implementation of continuous renal replacement therapy, in conjunction with anti- inflammatory treatment and life support, enabled the reduction of inflammatory mediators, correction of fluid overload, and achievement of hemodynamic stability.

Downloads

Download data is not yet available.

Downloads

Published

2026-08-31

How to Cite

1.
Kamariski M, LLano López LH, Julián P, Marinelli I. USE OF CONTINUOUS VENOVENOUS HEMODIAFILTRATION IN COVID-ASSOCIATED DIABETIC DEBUT. Rev Peru Pediatr [Internet]. 2026 Aug. 31 [cited 2026 Aug. 31];78(2):32-6. Available from: https://pediatria.pe/index.php/pedperu/article/view/627

Issue

Vol. 78 Num. 2 (2026)

Section

CLINICAL CASE

Categories

License

Copyright (c) 2026 Mariana Kamariski, Luis Hernán LLano López, Pablo Julián, Ivana Marinelli

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors will retain the copyright and grant the right to publish their work in the journal while allowing third parties to share it under the Creative Commons Attribution license.

Articles are published under a Creative Commons license that allows sharing and adaptation with appropriate credit. CC BY 4.0 license. Available in English at https://creativecommons.org/licenses/by/4.0/

Authors may use other information disclosure formats as long as the initial publication in the journal is cited. The dissemination of the work through the Internet is recommended to increase citations and promote academic exchanges.

The published content does not necessarily reflect the specific point of view of the journal, and the authors assume full responsibility for the content of their article.